Czechia, July 30 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Nemocnice Na Homolce for Antineoplastic Agents - Delivery of a medicinal product containing the active substance Nivolumab and ipilimumab. The value of the contract is worth 204530678 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....